AIM
OSIR

Acrospire Investment Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Acrospire Investment Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-12,610
Closed -$62K – 2737
2016
Q4 		$62K Buy
12,610
+10,019
+387% +$51.3K 0.03% 1265
2016
Q3 		$13K Sell
2,591
-10,985
-81% -$56.2K 0.01% 1645
2016
Q2 		$69K Buy
13,576
+2,218
+20% +$11.9K 0.05% 805
2016
Q1 		$65K Buy
+11,358
New +$79.3K 0.05% 706

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Acrospire Investment Management's OSIR Position: Q1 2017 in Review

Acrospire Investment Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 12,610 shares — an estimated $62K sold.

Acrospire Investment Management first reported a position in OSIR in Q1 2016 and held it in 4 quarters. The position peaked at $69K in Q2 2016. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • Acrospire Investment Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 12,610 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $62K.
  • Acrospire Investment Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Osiris Therapeutics, Inc. Common Stock position peaked at $69K in Q2 2016.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.